In vitro maturation of monocyte-derived dendritic cells results in two populations of cells with different surface marker expression, independently of applied concentration of interleukin-4

Dendritic cells (DCs) play a crucial role in the development of adaptive immune response. Monocyte-derived dendritic cells (MDDCs) are generated in vitro to study DC biology and for use in immunotherapy. However, procedures to generate MDDCs vary and an impact this may have on their final phenotype...

Full description

Saved in:

Bibliographic Details
Published in:	International immunopharmacology 2018-04, Vol.57, p.165-171
Main Authors:	Wołkow, Paweł P., Gębska, Anna, Korbut, Ryszard
Format:	Article
Language:	eng
Subjects:	Adaptive immunity Blood donors CC chemokine receptors CCR7 protein CD14 antigen CD40 antigen CD80 antigen CD83 antigen CD86 antigen Cell culture Cell surface Colony-stimulating factor Cytokines Dendritic cell maturation Dendritic cells Dendritic structure Flow cytometry Fluorescence Granulocyte-macrophage colony stimulating factor Histocompatibility antigen HLA Immune response Immune system Immunotherapy Interleukin Interleukin 4 Interleukin 4 (IL4) Leukocytes (granulocytic) Macrophages Markers Monocyte-derived dendritic cells (MDDCs) Monocytes Phenotypes Populations Prostaglandin E2 Staining Surface markers
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Dendritic cells (DCs) play a crucial role in the development of adaptive immune response. Monocyte-derived dendritic cells (MDDCs) are generated in vitro to study DC biology and for use in immunotherapy. However, procedures to generate MDDCs vary and an impact this may have on their final phenotype is insufficiently studied. Monocytes isolated from healthy blood donors were cultured for 7 days with granulocyte-macrophage colony stimulating factor (50 ng/mL) and low (500 IU/mL, L-IL4) or high (1000 IU/mL, H-IL4) interleukin 4 (IL4), to obtain immature DCs and for the following 2 days with addition of soluble CD40 ligand (500 ng/mL) and prostaglandin E2 (1 μg/mL) to obtain mature DCs. We measured mean fluorescence activity and percentage of cells, positive for CD14, HLA-DR, CD80, CD83, CD86, CCR7, and CD1a or CD209 markers after 7 and 9 days of culture, in both IL4 concentrations. Percentage of positively staining mature MDDCs was higher than among immature cells, for all studied markers. Interestingly, varying IL4 concentrations had negligible impact on staining of mature MDDCs. However, immature L-IL4 cultured MDDCs were less intensely stained for HLA-DR and CD209 than H-IL4 immature DCs. Flow cytometry revealed presence of 2 populations of cells (dominant P1 and less prevalent P2), when either L-IL4 or H-IL4 was used. Among mature MDDCs, population P1 had higher percentage of positively staining cells than P2, for all studied markers except CCR7. In conclusion, both concentrations of IL4 produce in vitro heterogeneous populations of mature MDDCs with similar staining for cell surface markers. •Mature human monocyte derived dendritic cells (MDDCs) form two subpopulations.•Expression of cell surface molecules differentiates two subpopulations of MDDCs.•Dominant subpopulation has higher expression of maturation and stimulation markers.•However, expression of CCR7 receptor is similar in both subpopulations.•IL-4 concentration has negligible effect on MDDCs' surface molecule expression.
ISSN:	1567-5769 1878-1705